Emedgene Technologies
Latest round
- Series A
Last raised
- Feb 2019
Total raised
- $6M
Investors
- 4
About Emedgene Technologies
Emedgene Technologies Ltd.Emedgene Technologies Ltd. provides software solutions for genetic variant interpretation. The company was co-founded by Einat Metzer and Niv Mizrahi, with Einat Metzer serving as the CEO.00 mn.Emedgene specializes in advanced software solutions for germline variant interpretation, focusing on streamlining tertiary analysis workflows for rare diseases and genetic research applications. Their flagship product, Emedgene variant interpretation software, utilizes explainable AI (XAI) and automation to improve user-defined variant interpretation, prioritization, curation, and research report generation. It integrates seamlessly with existing laboratory workflows, such as whole-genome sequencing (WGS) and whole-exome sequencing (WES), enabling analysis of various variant types, including single nucleotide variants (SNVs), insertions and deletions (indels), and copy number variants (CNVs).Emedgene's revenue model is subscription-based, where clients pay for access to the platform based on data volume and functionalities required. The company engages in direct B2B transactions with clinical laboratories and research facilities utilizing its software for genomic data analysis. Revenue is generated through annual subscription contracts that may include onboarding services, training, and ongoing technical support. The pricing structure accommodates different client needs, with options tailored for institutions conducting routine genetic testing and those involved in extensive research projects.Emedgene is focused on developing new software products to enhance its service offerings. The company plans to expand into additional markets in Europe and Asia by the end of 2023.
Who invested in Emedgene Technologies
4 investors across 2 rounds
See all investors in Emedgene Technologies
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Emedgene Technologies
Who invested in Emedgene Technologies?
Emedgene Technologies has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Emedgene Technologies raised?
Emedgene Technologies has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Emedgene Technologies last raise money?
Emedgene Technologies's most recent round on record is a Series A, in Feb 2019.
What does Emedgene Technologies do?
Emedgene Technologies is a software company.
Where is Emedgene Technologies headquartered?
Emedgene Technologies is headquartered in Palo Alto, US.
Which VCs invest in companies like Emedgene Technologies?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back software companies at Emedgene Technologies's stage. Their profiles are linked below.
VCs backing software startups at Series A
Raising like Emedgene Technologies? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.